Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion type Assertion NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_head.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion description "[Furthermore, mutations in the death domain of TRAIL-R2 were reported in 10.6% of non-small cell lung cancer (NSCLC) patients in a Korean population, suggesting a role for TRAIL-R2 in lung tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_provenance.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion evidence source_evidence_literature NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_provenance.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion SIO_000772 11205299 NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_provenance.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion wasDerivedFrom befree-20150227 NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_provenance.
- NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_assertion wasGeneratedBy ECO_0000203 NP805801.RAFKwGhtcXSEb6mY15qUmSjefZlg51KlEYbb5Vt2PXvSM130_provenance.